CVR number 10112079
Industry 75.0000 Veterinary activities

AKU DYREKLINIK ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.5% 6.6% 12.3% 7.2% 7.8%  
Credit score (0-100)  42 36 18 33 30  
Credit rating  BBB BBB BB BBB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  221 67.0 784 -38.6 44.3  
EBITDA  176 22.0 739 -89.3 44.3  
EBIT  134 -20.4 713 -115 18.3  
Pre-tax profit (PTP)  86.4 -43.0 689.5 -125.1 -25.8  
Net earnings  63.9 -43.0 616.3 -125.1 -25.8  
Pre-tax profit without non-rec. items  86.4 -43.0 690 -125 -25.8  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  4,419 4,376 111 2,659 2,633  
Shareholders equity total  686 643 710 585 559  
Interest-bearing liabilities  1,947 1,807 77.7 490 453  
Balance sheet total (assets)  4,429 4,421 2,745 2,752 2,643  
Net Debt  1,947 1,771 -2,556 403 444  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  221 67.0 784 -38.6 44.3  
Gross profit growth  26.3% -69.7% 1,069.9% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,429 4,421 2,745 2,752 2,643  
Balance sheet change%  -1.0% -0.2% -37.9% 0.3% -4.0%  
Added value  176.2 22.0 738.7 -89.3 44.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -85 -85 -3,742 1,973 -52  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 -1.0 1.0 -1.0 1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  60.5% -30.5% 90.9% 298.8% 41.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  3.0% -0.5% 19.9% -4.2% 0.7%  
ROI %  4.9% -0.8% 44.0% -12.4% 1.8%  
ROE %  9.8% -6.5% 91.1% -19.3% -4.5%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  15.5% 14.5% 25.9% 21.2% 21.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  1,105.4% 8,050.5% -346.0% -451.2% 1,001.8%  
Gearing %  283.8% 281.0% 10.9% 83.8% 81.0%  
Net interest  0 0 0 0 0  
Financing costs %  4.2% 1.2% 2.5% 3.5% 9.4%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.0 1.3 0.0 0.0  
Current Ratio  0.0 0.0 1.3 0.0 0.0  
Cash and cash equivalent  0.0 36.6 2,634.0 87.0 8.7  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -2,043.3 -2,214.3 599.1 -2,074.4 -2,074.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0